[go: up one dir, main page]

CA2006267A1 - Methode de traitement de l'herpes - Google Patents

Methode de traitement de l'herpes

Info

Publication number
CA2006267A1
CA2006267A1 CA2006267A CA2006267A CA2006267A1 CA 2006267 A1 CA2006267 A1 CA 2006267A1 CA 2006267 A CA2006267 A CA 2006267A CA 2006267 A CA2006267 A CA 2006267A CA 2006267 A1 CA2006267 A1 CA 2006267A1
Authority
CA
Canada
Prior art keywords
herpesviruses
treating
derivatives
glucitol
dideoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2006267A
Other languages
English (en)
Other versions
CA2006267C (fr
Inventor
Raymond Allen Dwek
Gary Steven Jacob
Albert Stanley Tyms
Thomas William Rademacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of CA2006267A1 publication Critical patent/CA2006267A1/fr
Application granted granted Critical
Publication of CA2006267C publication Critical patent/CA2006267C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002006267A 1988-12-22 1989-12-21 Methode de traitement de l'herpes Expired - Fee Related CA2006267C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US288,528 1988-12-22
US07/288,528 US4957926A (en) 1988-12-22 1988-12-22 Method of treating herpesviruses

Publications (2)

Publication Number Publication Date
CA2006267A1 true CA2006267A1 (fr) 1990-06-22
CA2006267C CA2006267C (fr) 2000-05-02

Family

ID=23107522

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002006267A Expired - Fee Related CA2006267C (fr) 1988-12-22 1989-12-21 Methode de traitement de l'herpes

Country Status (8)

Country Link
US (1) US4957926A (fr)
EP (1) EP0378984B1 (fr)
JP (1) JP2831068B2 (fr)
AT (1) ATE142496T1 (fr)
CA (1) CA2006267C (fr)
DE (1) DE68927160T2 (fr)
ES (1) ES2091766T3 (fr)
GR (1) GR3021845T3 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5342951A (en) * 1992-04-01 1994-08-30 G.D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5216168A (en) * 1992-04-01 1993-06-01 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5331096A (en) * 1992-04-01 1994-07-19 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5268482A (en) * 1992-04-01 1993-12-07 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
PT739205E (pt) * 1994-01-13 2000-04-28 Monsanto Co Utilizacao de derivados de 1,5-didesoxi-1,5-imino-d-glucitol para o tratamento de infeccoes com o virus da hepatite b
WO1995022975A1 (fr) * 1994-02-25 1995-08-31 G.D. Searle & Co. Utilisation de 1-desoxynojirimycine et de ses derives pour traiter des mammiferes infectes par le virus syncytial respiratoire
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
ES2216327T3 (es) 1997-11-10 2004-10-16 G.D. SEARLE & CO. Uso de iminoazucares alquilados para tratar la resistencia a multiples a farmacos.
DE69932154T2 (de) 1998-02-12 2007-05-31 G.D. Searle Llc, Chicago Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
WO2001008672A2 (fr) 1999-02-12 2001-02-08 G.D. Searle & Co. Composes glucamine destines au traitement d'infections dues au virus de l'hepatite
AU3595500A (en) * 1999-02-12 2000-08-29 G.D. Searle & Co. Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
EP1261339A1 (fr) * 2000-02-14 2002-12-04 Pharmacia Corporation UTILISATION DE COMPOSES 1,5-DIDESOXY-1,5-IMINO-D-GLUCITOL i N /i -SUBSTITUES POUR LE TRAITEMENT DES INFECTIONS PAR UN VIRUS D'HEPATITE
EP1181277A4 (fr) 2000-03-31 2005-08-10 Univ Michigan State Procede de preparation de 1,5-didesoxy-1,5-imino hexitols a partir d'oximes ou d'imines
WO2008045015A1 (fr) 2005-06-08 2008-04-17 Amicus Therapeutics, Inc. Purification d'imino- et amino-sucre
US8097728B2 (en) * 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
IT201700078102A1 (it) 2017-07-11 2019-01-11 Dipharma Francis Srl Sintesi di un azazucchero e suoi intermedi

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS63501925A (ja) * 1985-12-23 1988-08-04 フレツド　ハツチンソン　キヤンサ−　リサ−チ　センタ− レトロウイルスの複製、感染及び疾病誘発の制御

Also Published As

Publication number Publication date
ATE142496T1 (de) 1996-09-15
JP2831068B2 (ja) 1998-12-02
EP0378984A2 (fr) 1990-07-25
EP0378984B1 (fr) 1996-09-11
ES2091766T3 (es) 1996-11-16
JPH02212430A (ja) 1990-08-23
US4957926A (en) 1990-09-18
GR3021845T3 (en) 1997-02-28
DE68927160D1 (de) 1996-10-17
DE68927160T2 (de) 1997-03-20
EP0378984A3 (fr) 1992-07-08
CA2006267C (fr) 2000-05-02

Similar Documents

Publication Publication Date Title
CA2006267A1 (fr) Methode de traitement de l'herpes
PH30032A (en) Methods for inhibiting bone loss
CA2180535A1 (fr) Procede de traitement du psoriasis par omeprazole ou autres composes apparentes
TW275584B (fr)
HUT61196A (en) Process for producing pharmaceutical composition which may be dropped in the eye
WO1992009281A3 (fr) Utilisation de paroxetine pour le traitement de la demence senile, la boulimie, la migraine ou l'anorexie
WO1999012532A3 (fr) Derives de piperidine contre la malaria
PH25458A (en) Piperidine derivatives, therapeutic, preventive agents
AU7578694A (en) Methods for treating resistant neoplasms
AU2706888A (en) Method of inhibiting virus
AU2706788A (en) Method of inhibiting virus
CS274700B2 (en) Method of bu-3608 antibiotics' complex n-alkyl derivatives production
AU7777794A (en) Melatonin derivatives for use in treating sleep disorders
AU670491C (en) Pharmaceutical for the treatment of skin disorders
AU3934689A (en) New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
HUT59307A (en) Process for producing pharmaceutical compositions comprising zofenopril and suitable for treating arthritis
HU9201695D0 (en) Process for the production of a medical preparation effecting the nervous system
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
EP0370821A3 (fr) Dérivés de 1,4-dihydropyridine
EP0376608A3 (fr) Dérivés du benzamide utilisés comme agents antiarythmiques

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20051221